Governor Ned Lamont signed into law the Connecticut Artificial Intelligence Responsibility and Transparency Act. This legislation marks a substantial step in regulating artificial intelligence with far-reaching implications.
For many hospitals and safety-net providers, 340B savings are a financial lifeline that helps fund care for low-income and uninsured patients. That lifeline is facing new pressure as Eli Lilly becomes the first manufacturer to threaten suspension of 340B pricing for covered entities that do not submit in-house pharmacy claims data, placing critical savings and patient services at risk.
New York’s independent dispute resolution (IDR) process just changed significantly, which will have an impact on out-of-network providers. These sudden changes were passed at the eleventh hour as part of the budgetary process, which permits amending existing legislation as necessary to implement the budget.
With artificial intelligence (AI) technology becoming global, every information technology (IT) contract your organization enters into without appropriate data use restrictions can lead to your data and information being used for the purposes of training AI without your knowledge and for the sole benefit of the vendor
Website pixel tracking lawsuits remain active across the country—and health care organizations remain prime targets. While much of the focus is on existing website content, a quieter risk often arises earlier: in web development and rebranding contracts.